Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction

scientific article published on 27 May 2016

Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1031916379
P356DOI10.1186/S12933-016-0400-Y
P8608Fatcat IDrelease_7pmedjtzyjgqll6hwvy3lj3qw4
P932PMC publication ID4882784
P698PubMed publication ID27229923

P50authorMartin Bødtker MortensenQ55856237
P2093author name stringErling Falk
Imra Kulenovic
P2860cites workEuropean guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical PracticeQ49154329
The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study.Q50558006
Statin use prior to first myocardial infarction in contemporary patients: Inefficient and not gender equitableQ86944045
???Q22242898
Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionQ22242900
Active Smoking and the Risk of Type 2 DiabetesQ22252990
Standards of Medical Care in Diabetes--2015: Summary of RevisionsQ22255451
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesQ24608301
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)Q27860959
Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarctionQ28195833
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyQ28281870
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarctionQ29618673
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesQ29620108
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialQ29622926
Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarctionQ30576479
Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitusQ33961763
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialQ33966645
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).Q34196167
Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.Q34364949
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collabQ34368081
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectQ34534248
Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trialQ34822871
In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000-2010Q35026397
Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trialQ35106580
Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitusQ35128612
Association of obesity and long-term mortality in patients with acute myocardial infarction with and without diabetes mellitus: results from the MONICA/KORA myocardial infarction registryQ35402231
Cohort comparison study of cardiac disease and atherosclerotic burden in type 2 diabetic adults using whole body cardiovascular magnetic resonance imagingQ36071862
The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen General Population Study.Q36076136
Smoking in diabetic nephropathy: sparks in the fuel tank?Q38072702
Revisiting the links between glycaemia, diabetes and cardiovascular diseaseQ38077060
Dose-comparative effects of different statins on serum lipid levels: a network meta-analysis of 256,827 individuals in 181 randomized controlled trialsQ38093098
Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3).Q38199288
Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort StudyQ39918625
Low statin use in adults hospitalized with acute coronary syndromeQ40904895
Diabetes and cardiovascular disease. The Framingham studyQ41509493
Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical ImplicationsQ42537111
Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies.Q43427221
Improved quality of Type 2 diabetes care following electronic feedback of treatment status to general practitioners: a cluster randomized controlled trialQ43783493
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysisQ46810855
Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).Q46822432
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constitutedQ48527068
P407language of work or nameEnglishQ1860
P921main subjectmyocardial infarctionQ12152
P304page(s)81
P577publication date2016-05-27
P1433published inCardiovascular DiabetologyQ2468083
P1476titleStatin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction
P478volume15

Reverse relations

cites work (P2860)
Q55516148Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy.
Q37737452Atorvastatin Decreased Circulating RANTES Levels in Impaired Glucose Tolerance Patients with Hypercholesterolemia: An Interventional Study
Q41494768Effects of background statin therapy on glycemic response and cardiovascular events following initiation of insulin therapy in type 2 diabetes: a large UK cohort study
Q91750804Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia
Q47119196Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).

Search more.